These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 16554111)

  • 1. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of mass measles campaigns among children less than 5 years old in Uganda.
    Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A
    J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
    Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
    J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
    Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
    East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low-cost, community-based measles outbreak investigation with follow-up action.
    Weeks RM; Barenzi JF; Wayira JR
    Bull World Health Organ; 1992; 70(3):317-21. PubMed ID: 1638659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
    de Serres G; Boulianne N; Ratnam S; Corriveau A
    Pediatrics; 1996 Feb; 97(2):232-5. PubMed ID: 8584383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005.
    Atrasheuskaya AV; Kulak MV; Neverov AA; Rubin S; Ignatyev GM
    Vaccine; 2008 Apr; 26(17):2111-8. PubMed ID: 18343536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
    Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
    East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles antibody in the children in Ubon Ratchathani province.
    Saipan P; Jiwapaisarnpong T; Pattanadilok S; Loyha Y; Janggajit T
    J Med Assoc Thai; 2001 Apr; 84(4):500-6. PubMed ID: 11460960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
    Yuan L
    CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on measles vaccination rate and its antibody level in children aged 12-24 months in Guangxi, 1989].
    Lin M
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun; 13(3):138-40. PubMed ID: 1423535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
    MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 20. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate?
    McDonnell LF; Jorm LR; Patel MS
    Med J Aust; 1995 May; 162(9):471-5. PubMed ID: 7746203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.